Home Cart Sign in  
Chemical Structure| 3171-46-8 Chemical Structure| 3171-46-8
Chemical Structure| 3171-46-8

3,5-Dimethyl-1,2-benzenediamine

CAS No.: 3171-46-8

4.5 *For Research Use Only !

Cat. No.: A706928 Purity: 97%

Change View

Size Price

US Stock

Global Stock

In Stock
250mg łÇò¶ÊÊ Inquiry Inquiry
1g łËÿ¶ÊÊ Inquiry Inquiry
5g łďͶÊÊ Inquiry Inquiry
10g łÇ§î¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 250mg

    łÇò¶ÊÊ

  • 1g

    łËÿ¶ÊÊ

  • 5g

    łďͶÊÊ

  • 10g

    łÇ§î¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of [ 3171-46-8 ]

CAS No. :3171-46-8
Formula : C8H12N2
M.W : 136.19
SMILES Code : NC1=CC(C)=CC(C)=C1N
MDL No. :MFCD00972722
InChI Key :DMEPVFSJYHJGCD-UHFFFAOYSA-N
Pubchem ID :3613321

Safety of [ 3171-46-8 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Calculated chemistry of [ 3171-46-8 ] Show Less

Physicochemical Properties

Num. heavy atoms 10
Num. arom. heavy atoms 6
Fraction Csp3 0.25
Num. rotatable bonds 0
Num. H-bond acceptors 0.0
Num. H-bond donors 2.0
Molar Refractivity 45.18
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

52.04 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.49
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.29
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

1.48
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.48
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.31
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

1.41

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.94
Solubility 1.56 mg/ml ; 0.0115 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.98
Solubility 1.42 mg/ml ; 0.0104 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.42
Solubility 0.514 mg/ml ; 0.00378 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

Yes
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.21 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.0

Application In Synthesis of [ 3171-46-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 3171-46-8 ]

[ 3171-46-8 ] Synthesis Path-Downstream   1~29

  • 1
  • [ 1635-84-3 ]
  • [ 3171-46-8 ]
YieldReaction ConditionsOperation in experiment
With hydrogen;palladium 10% on activated carbon; In methanol; for 6.0h; To a solution of 4,6-dimethyl-2-nitroaniline (312 mg) in 5 mL MeOH, was added 10% Pd/C (50 mg). The mixture evacuated and flushed with H2 (3×), then was stirred under an atmosphere of H2 for 6 h. Conc. HCl (2 drops) was added and the mixture was stirred under H2 for an additional 18 h, then was filtered and concentrated to afford 280 mg of Intermediate 179.1, which was used without further purification.
With hydrogen;palladium 10% on activated carbon; In ethanol; under 760.051 Torr; for 3.0h; A mixture of 4,6-dimethyl-2-nitroaniline (10.0 g, 60.2 mmol) and 10% Pd/C (1.0 g) in EtOH (300 niL) was stirred under an atmosphere of hydrogen (ca. 1 atm) for 3 h, then filtered through a Celite pad and concentrated in vacuo. The crude solid was dissolved in CH3CN (200 mL) and triphosgene (15.0 g, 50.5 mmol) was added. The mixture was stirred for 1 h, then H2O (200 mL) was added slowly and stirring was continued for 1 h. The precipitate was isolated by filtration and dried to give the title compound. MS: mlz = 163 (M + 1).
  • 2
  • [ 90111-03-8 ]
  • [ 3171-46-8 ]
  • 3
  • [ 6417-44-3 ]
  • [ 3171-46-8 ]
  • 4
  • [ 84-11-7 ]
  • [ 3171-46-8 ]
  • [ 104352-47-8 ]
  • 5
  • [ 75-44-5 ]
  • [ 3171-46-8 ]
  • [ 102308-68-9 ]
  • 6
  • [ 64-18-6 ]
  • [ 3171-46-8 ]
  • [ 69557-54-6 ]
YieldReaction ConditionsOperation in experiment
at 150℃; for 0.08333330000000001h;microwave irradiation; Intermediate 179.1 (275 mg) in 3 mL formic acid was irradiated in a microwave reactor at 150 C. for 5 min. The mixture was diluted with water, neutralized with sat. NaHCO3, then extracted with EtOAc (3×). The organic phase was washed with water and brine, dried (Na2SO4) and concentrated to afford 245 mg of Intermediate 179.2 as an orange solid.
  • 7
  • [ 3171-46-8 ]
  • [ 108129-81-3 ]
  • 9
  • [ 603-35-0 ]
  • [ 3171-46-8 ]
  • [ 60190-73-0 ]
  • 10
  • [ 603-35-0 ]
  • [ 3171-46-8 ]
  • [ 60190-75-2 ]
  • 11
  • [ 824-72-6 ]
  • [ 3171-46-8 ]
  • [ 4602-06-6 ]
  • 12
  • [ 6374-26-1 ]
  • [ 3171-46-8 ]
  • C18H32N4O6P2S2 [ No CAS ]
  • 13
  • [ 3171-46-8 ]
  • [ 3497-00-5 ]
  • [ 4600-23-1 ]
  • 14
  • [ 3171-46-8 ]
  • [ 1557-63-7 ]
  • 20
  • [ 144-62-7 ]
  • [ 3171-46-8 ]
  • 5,7-dimethyl-1,4-dihydroquinoxaline-2,3-dione [ No CAS ]
  • 22
  • [ 7647-01-0 ]
  • [ 7782-50-5 ]
  • [ 64-19-7 ]
  • [ 3171-46-8 ]
  • 3,3,5,6-tetrachloro-4,6-dimethyl-cyclohex-4-ene-1,2-dione [ No CAS ]
  • 24
  • [ 7647-01-0 ]
  • [ 90111-03-8 ]
  • tin [ No CAS ]
  • [ 3171-46-8 ]
  • 25
  • [ 7647-01-0 ]
  • [ 6417-44-3 ]
  • tin [ No CAS ]
  • [ 95-68-1 ]
  • [ 3171-46-8 ]
  • 26
  • [ 89209-03-0 ]
  • [ 3171-46-8 ]
  • 27
  • [ 848847-23-4 ]
  • [ 3171-46-8 ]
  • 2-{2-chloro-4-[3-(4-methyl-piperazin-1-yl)-propoxy]-phenyl}-4,6-dimethyl-1H-benzoimidazole [ No CAS ]
  • 28
  • [ 919088-55-4 ]
  • [ 3171-46-8 ]
  • 2-{2-chloro-4-[3-(4-methyl-[1,4]diazepan-1-yl)-propoxy]-phenyl}-4,6-dimethyl-1H-benzoimidazole [ No CAS ]
  • 29
  • [ 24786-18-3 ]
  • [ 3171-46-8 ]
  • N-(5,7-dimethyl-1H-benzimidazol-2-yl)benzamide [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 3171-46-8 ]

Aryls

Chemical Structure| 2687-25-4

A358547 [2687-25-4]

3-Methylbenzene-1,2-diamine

Similarity: 0.96

Chemical Structure| 136583-84-1

A157266 [136583-84-1]

4-Ethylbenzene-1,2-diamine dihydrochloride

Similarity: 0.87

Chemical Structure| 1639-31-2

A838163 [1639-31-2]

3,4,5-Trimethylaniline

Similarity: 0.86

Chemical Structure| 131019-87-9

A305051 [131019-87-9]

N1,5-Dimethylbenzene-1,2-diamine

Similarity: 0.82

Chemical Structure| 32202-61-2

A238320 [32202-61-2]

2,3-Dihydro-1H-inden-4-amine

Similarity: 0.81

Amines

Chemical Structure| 2687-25-4

A358547 [2687-25-4]

3-Methylbenzene-1,2-diamine

Similarity: 0.96

Chemical Structure| 136583-84-1

A157266 [136583-84-1]

4-Ethylbenzene-1,2-diamine dihydrochloride

Similarity: 0.87

Chemical Structure| 1639-31-2

A838163 [1639-31-2]

3,4,5-Trimethylaniline

Similarity: 0.86

Chemical Structure| 131019-87-9

A305051 [131019-87-9]

N1,5-Dimethylbenzene-1,2-diamine

Similarity: 0.82

Chemical Structure| 32202-61-2

A238320 [32202-61-2]

2,3-Dihydro-1H-inden-4-amine

Similarity: 0.81